Keros Therapeutics Liability on Credit Line (Quarterly) Insights

Keros Therapeutics, Inc. (KROS)

15.55 -0.16 (-1.02%) USD | NASDAQ | Feb 24, 12:18

View Liability on Credit Line (Quarterly) for KROS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Liability on Credit Line (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Liability on Credit Line (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Liability on Credit Line (Quarterly) Benchmarks

Start Trial